Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Aethlon Medical Inc. logo

Aethlon Medical Inc.

Sector: Technology   

Industry: Scientific & Technical Instruments

1.68
 
USD
  
-0.03
  
(-1.75%)
Optionable: Yes  Market Cap: 5 M  90-day average vol: 8,730

Previous close: 1.71  Open: 1.74  Bid: 1.67  Ask: 1.78
52 week range    
1.40   
   7.20
Peers   
INO / 
COHR / 
BRKR / 
IDRA / 
PACB / 
AXDX / 
Last updated: Friday 29th March 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

AXDX

0 B-2.72.89

BRKR

0.002410 B37.667.44

COHR

6 B-58.9255.77

IDRA

0 B-0.20.5451

INO

1 B-3.93.8

PACB

3 B-93.211.01

PKI

0.001522 B17.1182.49
Financials

AEMD Income Statement

Annual
Mar-14Mar-15Mar-16Mar-17Mar-18Mar-19Mar-20Mar-21Mar-22Mar-23
Amortization of intangibles-9000.0-9000.0-9000.0-9165.0-9164.0-9164.0-9164.0-550.0-54754.0-550.0
Basic EPS from continuing operations-0.71-0.59
Basic EPS total-0.71-0.59
Basic weighted shares outstanding13 M372963.0492913.0517615.0821138.018 M3 M12 M15 M21 M
Depreciation-21087.0-28000.0-29000.0-23248.0-26494.0-21531.0-17202.0-39389.0-68931.0-240342.0
Depreciation unreconciled-37352.0-38524.0-32413.0-35658.0-30695.0-26366.0-39939.0
DepreciationAndAmortization-21087.0-37352.0-38524.0-32413.0-35658.0-30695.0-26366.0-39939.0-68931.0-240342.0
Diluted EPS total-1.05-18.3-9.9-14.1-6.9-0.07-1.87-0.65-0.71-0.59
Diluted normalized net income/share-1.87-0.65-0.71-0.59
Diluted weighted shares outstanding6 M371429.0492154.0516036.0823124.088 M3 M12 M15 M21 M
Earnings from equity interest51190.0-142121.0
EarningsFromEquityInterestNetOfTax51190.0-142121.0
GainOnSaleOfSecurity-9 M
GeneralAndAdministrativeExpense2 M2 M3 M3 M2 M3 M4 M5 M6 M8 M
Gross operating profit2 M762417.0886572.0392073.0149625.0229625.0701377.0659104.0294165.0574245.0
Income before tax-13 M-7 M-5 M-7 M-6 M-6 M-6 M-8 M-10 M-12 M
Income restructuring and M&A-9307.0-16433.0-24823.0-151665.0-59881.0-349193.0
Income taxes-8 M447011.0
Interest income40257.010973.0
InterestExpenseNonOperating-1 M-349923.0-573782.0-304330.0-361597.0-220487.0-54232.0-1580.0
MinorityInterests81730.0182337.086287.030613.020279.024785.06093.04790.04794.0
MiscOtherSpecialCharges75059.0-3 M-904039.0-376909.0-447011.0
Net income from total operations-13 M-7 M-5 M-7 M-6 M-6 M-6 M-8 M-10 M-12 M
NetIncomeCommonStockholders-13 M-7 M-5 M-7 M-6 M-6 M-6 M-8 M-10 M-12 M
NetIncomeContinuousOperations-13 M-7 M-5 M-7 M-6 M-6 M-6 M-8 M-10 M-12 M
NetIncomeExtraordinary-13 M
NetNonOperatingInterestIncomeExpense-1 M-452276.0-573782.0-304330.0-361597.0-220487.0-54232.0-1580.010973.0
NonRecurringOperationExpense583601.0
Operating income-3 M-4 M-4 M-6 M-5 M-6 M-6 M-8 M-10 M-12 M
Operating income before depreciation (EBITDA)-15 M-7 M-5 M-7 M-6 M-6 M-6 M-8 M-10 M-12 M
OperatingExpense-5 M-5 M-5 M-6 M-5 M-6 M7 M9 M11 M12 M
Other income net8 M3 M904039.0376909.0395821.0142121.0
OtherGandA2 M2 M3 M3 M2 M3 M4 M5 M6 M8 M
OtherOperatingExpenses40256.03 M130215.0
RentAndLandingFees931106.0907115.0929013.0849491.0792600.0953478.0-178000.0-192000.0-12080.0
Research & development expense-2 M-1 M-782000.0-673000.0-586000.0-896000.0-927000.0-2 M-2 M-3 M
ResearchExpense-2 M-3 M
RestructringAndMnAIncome-9307.0-16433.0-24823.0-151665.0-59881.0-349193.0
Revenue per share-9863.0-127147.0-153683.0-36806.0-9164.0-9164.0-9164.0-550.0-54754.0-550.0
SalariesAndWages2 M2 M2 M3 M3 M3 M2 M3 M5 M4 M
Selling Gen & administrative expense2 M2 M3 M3 M2 M3 M4 M5 M6 M8 M
Special income/charges-583601.09307.016433.024823.0151665.059881.0349193.0
Total Income available for interest expense (EBIT)-15 M-7 M-6 M-8 M-6 M-6 M-6 M-8 M-10 M-12 M
Total common shares outstanding337860.010147.0508159.0591304.01 M19 M12 M15 M16 M
Total net income-13 M-7 M-5 M-7 M-6 M-6 M-6 M-8 M-10 M-12 M
Total ordinary shares3 M3 M3 M3 M3 M3 M3 M3 M3 M3 M
Total revenues2 M762417.0886572.0392073.0149625.0229625.0701377.0659104.0294165.0574245.0
TotalExpenses-5 M-5 M-5 M-6 M-5 M-6 M7 M9 M11 M12 M
TotalRevenue2 M762417.0886572.0392073.0149625.0229625.0701377.0659104.0294165.0574245.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University